25
Jun
2024

Public Webinar: Can Endpoints from Digital Technology Provide Meaningful Outcomes for HTA?

RWE4Decisions is thrilled to annouce its upcoming webinar “Can endpoints from digital technology provide meaningful outcomes for Health Technology Assessment (HTA)?” taking place on Tuesday, 25 June from 15:00 to 16:30 CEST.

Join us for an expert discussion about how patient-generated health data could be analysed to support Health Technology Assessment (HTA) bodies and Payers, delving into issues such as app governance models, the use of AI and more.


PROGRAMME

15:00

Welcome from the co-moderators

  • Eric Sutherland
    Senior Health Economist, OECD
    Alina Pavel
    RWE4Decisions Secretariat
15:05

Presentations

  • Patient-controlled information flows and HTA in the global cystic fibrosis community
    Andreas Hager
    Board Member, Cystic Fibrosis Europe
  • Strategies for Development, Governance, and Assessment of Digital Health Technologies at Hospital Level
    Rossella di Bidino
    Head of the HTA for AI Unit, ALTEMS Università Cattolica
15:30

Panel discussion

  • Anja Schiel
    Senior Advisor, Methodologist in Regulatory and Pharmacoeconomic Statistics, Norwegian Medicinal Products Agency (NOMA)
  • Lara Wolfson
    Associate Vice-President & Head HTA Statistics, MSD; Co-Chair, PSI/EFPSI HTA Special Interest Group
16:05

Q&A with audience

16:25

Next steps

16:30

Meeting close